Ignite Creation Date:
2024-05-06 @ 3:07 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02203513
Status:
TERMINATED
Last Update Posted:
2022-09-10
First Post:
2014-07-29
Brief Title:
A Phase II Single Arm Pilot Study of the Chk12 Inhibitor LY2606368 in BRCA12 Mutation Associated Breast or Ovarian Cancer Triple Negative Breast Cancer High Grade Serous Ovarian Cancer and Metastatic Castrate-Resistant Prostate Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
140156
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
Jung-Min Lee MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Cancer Institute NCI
Old Name:
None
Old Organization:
None